- Home
- CANF vs SDOT Comparison
CANF vs SDOT Comparison
Compare CANF & SDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CANF | SDOT |
|---|---|---|
| Founded | 1994 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 4.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CANF | SDOT |
|---|---|---|
| Price | $4.11 | $2.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9,750.00 | N/A |
| AVG Volume (30 Days) | 74.6K | ★ 442.2K |
| Earning Date | 03-26-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $560,000.00 | ★ $467,078,000.00 |
| Revenue This Year | $461.72 | $12.76 |
| Revenue Next Year | N/A | $5.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.36 | $1.17 |
| 52 Week High | $46.60 | $35.60 |
Technical Indicators
Market Signals| Indicator | CANF | SDOT |
|---|---|---|
| Relative Strength Index (RSI) | 64.56 | 47.53 |
| Support Level | $4.00 | $2.83 |
| Resistance Level | $4.32 | $3.18 |
| Average True Range (ATR) | 0.29 | 0.35 |
| MACD | -0.16 | -0.03 |
| Stochastic Oscillator | 31.61 | 26.46 |
Price Performance
Historical ComparisonAbout CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.